Immucor Spiking On Takeover Rumors (BLUD)
Immucor, Inc. (NASDAQ: BLUD) is spiking, up some 3% on reports that Dealreporter is reporting private equity interest in the company.
According to the source, at least two financial sponsors may be circling Immucor.
Immucor, Inc. engages in the development, manufacture, and sale of reagents and automated systems.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: dealREPORTERNews Rumors Movers